Seeing Is Believing
CERE is currently covered by 9 analysts with an average price target of $49.5. This is a potential upside of $4.54 (10.1%) from yesterday's end of day stock price of $44.96.
Cerevel Therapeutics Holdings's activity chart (see below) currently has 37 price targets and 42 ratings on display. The stock rating distribution of CERE is 73.33% HOLD and 26.67% BUY.
Analysts average stock forecasts to be materialized ratio is 56.79% with an average time for these price targets to be met of 114.57 days.
Highest price target for CERE is $43, Lowest price target is $21, average price target is $38.89.
Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 16-Feb-2024.
Currently out of the existing stock ratings of CERE, 11 are a HOLD (73.33%), 4 are a BUY (26.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$45
$0.04 (0.09%)
$25
1 years 1 months 20 days ago
(16-Feb-2024)
9/10 (90%)
$2.43 (5.71%)
63
Hold
$45
$0.04 (0.09%)
$25
1 years 3 months 8 days ago
(28-Dec-2023)
3/4 (75%)
$2.56 (6.03%)
136
Hold
$45
$0.04 (0.09%)
1 years 3 months 28 days ago
(08-Dec-2023)
0/1 (0%)
$3.78 (9.17%)
Hold
$45
$0.04 (0.09%)
$41
1 years 3 months 29 days ago
(07-Dec-2023)
1/6 (16.67%)
$3.87 (9.41%)
126
Hold
$38
$-6.96 (-15.48%)
$46
1 years 3 months 29 days ago
(07-Dec-2023)
1/3 (33.33%)
$-3.13 (-7.61%)
434
What is CERE (Cerevel Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on CERE (Cerevel Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most bullish on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most reserved on CERE (Cerevel Therapeutics Holdings)?